Recurrent Large Cell Lung Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent Large Cell Lung Carcinoma
| Record | Firm | Date |
|---|---|---|
| Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT03845296) | SWOG Cancer Research Network | 2019-04-16 |
| S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT00946712) | SWOG Cancer Research Network | 2009-07-15 |
Track Recurrent Large Cell Lung Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.